These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 9783980)

  • 21. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
    De Leeuw WJ; Berx G; Vos CB; Peterse JL; Van de Vijver MJ; Litvinov S; Van Roy F; Cornelisse CJ; Cleton-Jansen AM
    J Pathol; 1997 Dec; 183(4):404-11. PubMed ID: 9496256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. E-cadherin and catenins in early squamous cervical carcinoma.
    Van de Putte G; Kristensen GB; Baekelandt M; Lie AK; Holm R
    Gynecol Oncol; 2004 Aug; 94(2):521-7. PubMed ID: 15297198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer.
    Yoshida R; Kimura N; Harada Y; Ohuchi N
    Int J Oncol; 2001 Mar; 18(3):513-20. PubMed ID: 11179480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significance of E-cadherin/beta-catenin complex and cyclin D1 in breast cancer.
    Lim SC; Lee MS
    Oncol Rep; 2002; 9(5):915-28. PubMed ID: 12168049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction in membranous expression of beta-catenin and increased cytoplasmic E-cadherin expression predict poor survival in gastric cancer.
    Ramesh S; Nash J; McCulloch PG
    Br J Cancer; 1999 Dec; 81(8):1392-7. PubMed ID: 10604738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of E-cadherin, alpha, beta and gamma-catenin in human colorectal cancer.
    Hiscox S; Jiang WG
    Anticancer Res; 1997; 17(2B):1349-54. PubMed ID: 9137497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of E-cadherin and catenins in invasive mammary carcinomas.
    Zschiesche W; Schönborn I; Behrens J; Herrenknecht K; Hartveit F; Lilleng P; Birchmeier W
    Anticancer Res; 1997; 17(1B):561-7. PubMed ID: 9066580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-cadherin-catenin interaction: necessary component of cardiac cell compartmentalization during early vertebrate heart development.
    Linask KK; Knudsen KA; Gui YH
    Dev Biol; 1997 May; 185(2):148-64. PubMed ID: 9187080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered expression of beta-catenin in renal cell cancer and transitional cell cancer with the absence of beta-catenin gene mutations.
    Bilim V; Kawasaki T; Katagiri A; Wakatsuki S; Takahashi K; Tomita Y
    Clin Cancer Res; 2000 Feb; 6(2):460-6. PubMed ID: 10690524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of integrin, cadherin, and catenin expression in squamous cell carcinomas of the oral cavity.
    Bagutti C; Speight PM; Watt FM
    J Pathol; 1998 Sep; 186(1):8-16. PubMed ID: 9875134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The expression of E-cadherin and catenins in sporadic colorectal carcinoma.
    El-Bahrawy MA; Poulsom R; Jeffery R; Talbot I; Alison MR
    Hum Pathol; 2001 Nov; 32(11):1216-24. PubMed ID: 11727261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression and tyrosine phosphorylation of E-cadherin, beta- and gamma-catenin, and epidermal growth factor receptor in cervical cancer cells.
    Moon HS; Choi EA; Park HY; Choi JY; Chung HW; Kim JI; Park WI
    Gynecol Oncol; 2001 Jun; 81(3):355-9. PubMed ID: 11371122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. E-cadherin and alpha-, beta- and gamma-catenin expression in prostate cancers: correlation with tumour invasion.
    Morita N; Uemura H; Tsumatani K; Cho M; Hirao Y; Okajima E; Konishi N; Hiasa Y
    Br J Cancer; 1999 Apr; 79(11-12):1879-83. PubMed ID: 10206308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and prognostic significance of an epithelial-mesenchymal transition expression profile in human bladder tumors.
    Baumgart E; Cohen MS; Silva Neto B; Jacobs MA; Wotkowicz C; Rieger-Christ KM; Biolo A; Zeheb R; Loda M; Libertino JA; Summerhayes IC
    Clin Cancer Res; 2007 Mar; 13(6):1685-94. PubMed ID: 17363521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cadherin switching dictates the biology of transitional cell carcinoma of the bladder: ex vivo and in vitro studies.
    Bryan RT; Atherfold PA; Yeo Y; Jones LJ; Harrison RF; Wallace DM; Jankowski JA
    J Pathol; 2008 Jun; 215(2):184-94. PubMed ID: 18393367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta- and gamma-catenin expression in oral squamous cell carcinomas.
    Lo Muzio L; Staibano S; Pannone G; Grieco M; Mignogna MD; Cerrato A; Testa NF; De Rosa G
    Anticancer Res; 1999; 19(5B):3817-26. PubMed ID: 10628318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical patterns for alpha- and beta-catenin, E- and N-cadherin expression in ovarian epithelial tumors.
    Marques FR; Fonsechi-Carvasan GA; De Angelo Andrade LA; Böttcher-Luiz F
    Gynecol Oncol; 2004 Jul; 94(1):16-24. PubMed ID: 15262114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the E-cadherin-catenin complexes in pancreatic carcinoma cell lines.
    El-Hariry I; Jordinson M; Lemoine N; Pignatelli M
    J Pathol; 1999 Jun; 188(2):155-62. PubMed ID: 10398158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant E-cadherin and gamma-catenin expression in malignant mesothelioma and its diagnostic and biological relevance.
    Orecchia S; Schillaci F; Salvio M; Libener R; Betta PG
    Lung Cancer; 2004 Aug; 45 Suppl 1():S37-43. PubMed ID: 15261432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cadherin-catenin expression in primary colorectal cancer: a survival analysis.
    Hugh TJ; Dillon SA; Taylor BA; Pignatelli M; Poston GJ; Kinsella AR
    Br J Cancer; 1999 Jun; 80(7):1046-51. PubMed ID: 10362114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.